ZA935341B - Phenylimidazolidine derivatives, their preparation and their use - Google Patents
Phenylimidazolidine derivatives, their preparation and their useInfo
- Publication number
- ZA935341B ZA935341B ZA935341A ZA935341A ZA935341B ZA 935341 B ZA935341 B ZA 935341B ZA 935341 A ZA935341 A ZA 935341A ZA 935341 A ZA935341 A ZA 935341A ZA 935341 B ZA935341 B ZA 935341B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- phenylimidazolidine
- derivatives
- phenylimidazolidine derivatives
- nhr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/40—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4224414A DE4224414A1 (de) | 1992-07-24 | 1992-07-24 | Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935341B true ZA935341B (en) | 1994-02-14 |
Family
ID=6463969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935341A ZA935341B (en) | 1992-07-24 | 1993-07-23 | Phenylimidazolidine derivatives, their preparation and their use |
Country Status (16)
Country | Link |
---|---|
US (1) | US5424293A (ko) |
EP (1) | EP0580008B1 (ko) |
JP (1) | JP3775808B2 (ko) |
KR (1) | KR100418321B1 (ko) |
AT (1) | ATE168116T1 (ko) |
AU (1) | AU664630B2 (ko) |
CA (1) | CA2101179C (ko) |
CZ (1) | CZ289297B6 (ko) |
DE (2) | DE4224414A1 (ko) |
DK (1) | DK0580008T3 (ko) |
ES (1) | ES2119837T3 (ko) |
HU (1) | HU220767B1 (ko) |
IL (1) | IL106462A (ko) |
SK (1) | SK282517B6 (ko) |
TW (1) | TW306918B (ko) |
ZA (1) | ZA935341B (ko) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4308034A1 (de) * | 1993-03-13 | 1994-09-15 | Cassella Ag | Neue Heterocyclen, ihre Herstellung und ihre Verwendung |
DE4427979A1 (de) | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
EP0796855B1 (de) | 1996-03-20 | 2002-02-06 | Hoechst Aktiengesellschaft | Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
DE19622489A1 (de) | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
PL323130A1 (en) * | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
DE19647381A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
DE19741235A1 (de) * | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19751251A1 (de) * | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6163155A (en) * | 1999-01-28 | 2000-12-19 | Dresser Industries, Inc. | Electromagnetic wave resistivity tool having a tilted antenna for determining the horizontal and vertical resistivities and relative dip angle in anisotropic earth formations |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6569876B1 (en) | 1999-06-17 | 2003-05-27 | John C. Cheronis | Method and structure for inhibiting activity of serine elastases |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE10137595A1 (de) * | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
CN101501297B (zh) * | 2006-07-11 | 2013-10-16 | 哈里伯顿能源服务公司 | 模块化地质导向工具组件 |
CN101479628B (zh) * | 2006-07-12 | 2012-10-03 | 哈里伯顿能源服务公司 | 用于制造倾斜天线的方法和装置 |
AU2007349251B2 (en) * | 2007-03-16 | 2011-02-24 | Halliburton Energy Services, Inc. | Robust inversion systems and methods for azimuthally sensitive resistivity logging tools |
US8581592B2 (en) | 2008-12-16 | 2013-11-12 | Halliburton Energy Services, Inc. | Downhole methods and assemblies employing an at-bit antenna |
GB2486759B (en) | 2010-01-22 | 2014-09-03 | Halliburton Energy Serv Inc | Method and apparatus for resistivity measurements |
AU2012383577B2 (en) | 2012-06-25 | 2015-07-09 | Halliburton Energy Services, Inc. | Tilted antenna logging systems and methods yielding robust measurement signals |
EP3286172B1 (en) | 2015-04-23 | 2019-06-12 | Constellation Pharmaceuticals, Inc. | Lsd1 inhibitors and uses thereof |
PL3532459T3 (pl) | 2016-10-26 | 2024-06-24 | Constellation Pharmaceuticals, Inc. | Inhibitory lsd1 i ich zastosowania medyczne |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
DE4213634A1 (de) * | 1992-04-24 | 1993-10-28 | Cassella Ag | 2,4-Dioxo-imidazolidin-Derivate |
-
1992
- 1992-07-24 DE DE4224414A patent/DE4224414A1/de not_active Withdrawn
-
1993
- 1993-07-01 JP JP16304293A patent/JP3775808B2/ja not_active Expired - Fee Related
- 1993-07-06 ES ES93110754T patent/ES2119837T3/es not_active Expired - Lifetime
- 1993-07-06 AT AT93110754T patent/ATE168116T1/de not_active IP Right Cessation
- 1993-07-06 DE DE59308732T patent/DE59308732D1/de not_active Expired - Lifetime
- 1993-07-06 EP EP93110754A patent/EP0580008B1/de not_active Expired - Lifetime
- 1993-07-06 DK DK93110754T patent/DK0580008T3/da active
- 1993-07-21 CZ CZ19931475A patent/CZ289297B6/cs not_active IP Right Cessation
- 1993-07-21 SK SK769-93A patent/SK282517B6/sk unknown
- 1993-07-22 US US08/095,905 patent/US5424293A/en not_active Expired - Lifetime
- 1993-07-23 AU AU42119/93A patent/AU664630B2/en not_active Ceased
- 1993-07-23 CA CA002101179A patent/CA2101179C/en not_active Expired - Fee Related
- 1993-07-23 KR KR1019930013987A patent/KR100418321B1/ko not_active IP Right Cessation
- 1993-07-23 ZA ZA935341A patent/ZA935341B/xx unknown
- 1993-07-23 IL IL10646293A patent/IL106462A/xx not_active IP Right Cessation
- 1993-07-23 HU HU9302138A patent/HU220767B1/hu not_active IP Right Cessation
- 1993-07-24 TW TW082105953A patent/TW306918B/zh active
Also Published As
Publication number | Publication date |
---|---|
DE59308732D1 (de) | 1998-08-13 |
JPH0725855A (ja) | 1995-01-27 |
AU4211993A (en) | 1994-01-27 |
CA2101179C (en) | 2003-10-28 |
SK282517B6 (sk) | 2002-10-08 |
IL106462A0 (en) | 1993-11-15 |
EP0580008A3 (de) | 1995-03-15 |
ES2119837T3 (es) | 1998-10-16 |
AU664630B2 (en) | 1995-11-23 |
EP0580008B1 (de) | 1998-07-08 |
JP3775808B2 (ja) | 2006-05-17 |
EP0580008A2 (de) | 1994-01-26 |
DK0580008T3 (da) | 1999-02-08 |
CA2101179A1 (en) | 1994-01-25 |
HU9302138D0 (en) | 1993-10-28 |
IL106462A (en) | 1997-02-18 |
DE4224414A1 (de) | 1994-01-27 |
KR100418321B1 (ko) | 2004-05-07 |
SK76993A3 (en) | 1994-04-06 |
TW306918B (ko) | 1997-06-01 |
ATE168116T1 (de) | 1998-07-15 |
CZ289297B6 (cs) | 2001-12-12 |
CZ147593A3 (en) | 1994-03-16 |
HUT65141A (en) | 1994-04-28 |
US5424293A (en) | 1995-06-13 |
HU220767B1 (hu) | 2002-05-28 |
KR940005583A (ko) | 1994-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA935341B (en) | Phenylimidazolidine derivatives, their preparation and their use | |
BG100951A (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
AU583055B2 (en) | Tetralin derivatives, their preparation and their use | |
EG19999A (en) | Process for preparing of piperazinyl - and piperidinyl cyclohexanols | |
TW248559B (ko) | ||
CA2080249A1 (en) | Preparation of substituted piperidines | |
AU4611589A (en) | Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof. | |
NZ216750A (en) | Morpholino derivatives and fungicides | |
AU1413788A (en) | Dihydropyridinamides process for their preparation, and their use in medicaments | |
AU579869B2 (en) | 4-amino-8-alkylthio-2-piperazino-pyrimido ``5,4-d`` pyrimidines | |
ZA88446B (en) | Allylmercaptoacetylsydnonimines,processes for their preparation, and their use | |
KR960004860B1 (en) | Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments | |
DE3783009D1 (ko) | ||
ES2001665A6 (es) | Procedimiento para preparar tripeptidos alquilados en n | |
HU9300181D0 (en) | Alpha-aryl-alpha-hydroxi-beta-imidazolinyl-propionic acid amide | |
HUT73562A (en) | Thiocarbamoyl-pyrazole derivatives, keto-carboxylic acid ester intermediates thereof, preparations thereof, using the pyrazole derivatives and microbicide compositions containing these compounds | |
AU4370489A (en) | The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents | |
IE893533L (en) | Substituted 3-aminosydnonimines, processes for their¹preparation and their use | |
ZA874596B (en) | 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroaryl-(thio)ureas | |
ES2000283A6 (es) | Procedimiento para preparar nuevas cetoaminas cicloalifaticas | |
CA2012661A1 (en) | Thienylpiperazines, process for the Preparation Thereof, the Use Thereof, and Pharmaceuticals Containing These and the Preparation Thereof | |
ES8703421A1 (es) | Procedimiento para preparar derivados de pirrolidindiona. |